Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed Phase II ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback